Ibiden (4062) Q1 2027 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2027 earnings summary
4 Aug, 2026Executive summary
Net sales for the first quarter ended June 30, 2026, rose 26.4% year-over-year to ¥123,219 million, with operating profit up 52.4% to ¥26,880 million and profit attributable to owners of parent up 40.8% to ¥17,918 million.
Comprehensive income decreased 8.8% year-over-year to ¥19,190 million.
Financial highlights
Gross profit increased by ¥9,801 million year-over-year to ¥44,873 million, with a gross margin improvement.
Basic earnings per share for the quarter were ¥64.14, reflecting the impact of a stock split.
Cash and deposits rose to ¥373,366 million, up ¥77,684 million from March 2026.
Net cash provided by operating activities surged to ¥95,892 million, up ¥86,329 million year-over-year.
Outlook and guidance
Full-year FY2026 net sales forecast is ¥550,000 million, up 32.1% year-over-year, with operating income expected to double to ¥127,000 million.
Profit attributable to owners of parent is projected at ¥84,000 million, up 31.8% year-over-year.
EPS forecast for FY2026 is ¥149.68, or ¥299.35 without considering the October 2026 stock split.
Latest events from Ibiden
- Strong sales and profit growth, robust electronics, and a 2-for-1 stock split highlight outlook.4062
Q4 202612 May 2026 - Strong Q3 growth, stock split, and major investment plan to boost high-performance IC substrate capacity.4062
Q3 20263 Feb 2026 - Strong sales and profit growth, stock split, and robust outlook driven by electronics.4062
Q2 202631 Oct 2025 - Strong first-quarter growth driven by electronics, with raised full-year outlook.4062
Q1 20261 Aug 2025 - Operating profit rose 38% despite a 7% sales decline, with strong cash flow and stable outlook.4062
Q1 202513 Jun 2025 - Profit growth offset lower sales, but comprehensive income dropped on market-related losses.4062
Q2 202513 Jun 2025 - Profit rose 7% in FY2024, but FY2025 net profit is forecast to decline amid tariff risks.4062
Q4 20256 Jun 2025 - Q3 sales and profit declined, but gross margin and capital adequacy improved.4062
Q3 20255 Jun 2025